Electronic Gateway Heralds Faster Submissions In Canada
Executive Summary
Health Canada is considering a pilot that should lead to medical device companies being able to use the common electronic submission gateway that is already in use by pharma. The gateway cuts transmission times.
You may also be interested in...
Canada Makes Headway On Pilot To Test E-Submission Gateway; Guidance For 3D-Printing
Canada will test the feasibility of receiving structured regulatory information from medical device sponsors through its common electronic gateway. Separately, a draft guideline on 3D-printed devices is in the works and is expected to be issued for consultation later this year.
Canada taps into US online gateway for faster drug submissions
Health Canada has started using a dedicated channel of the US Food and Administration's electronic submissions gateway (ESG) which for the first time allows pharmaceutical companies to submit drug authorization data online to the Canadian regulator1,2.
New EU Filings
Obecabtagene autoleucel, Autolus Therapeutics’s investigational treatment for relapsed or refractory B cell precursor acute lymphoblastic leukemia, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.